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educational level, alcohol consumption, smoking, blood pressure, LDL- and
HDL-cholesterol. The adjusted Hazard Ratio for all-cause mortality was 2.77
[95% confidence interval: 0.70-10.88]
 
for untreated diabetics, 2.15 [0.91-5.08]
for diabetics with metformin alone, 1.53 [0.81-2.89]
 
for diabetics with sulfo-
nylurea (alone or in combination) and 5.03 [1.99-12.71]
 
for diabetics with
insulin (alone or in combination) versus non-diabetic subjects.
Conclusions: Diabetics treated with insulin at baseline were at increased
risk of all-cause mortality. We did not find any harmful signal regarding all-
cause mortality risk associated with the use of other hypoglycemic drugs. 
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In developed countries, cardiac valve diseases are one of the major
causes of mortality and morbidity. Aortic valve disease (AVD) including
aortic insufficiency or aortic stenosis, mainly develop as a consequence of
valvular degeneration. This defect was considered to be related to ageing
however it is now viewed as a multifactorial complex. Despite the impor-
tance of the AVD, its etiology is poorly understood. To assess this ques-
tion we’ve used mouse model. Thus, we have found that the transcription
factor Krox20 (also called Egr2) is expressed in the developing valves
during gestation and maintained after birth. Mice lacking Krox20 die at
birth due to respiratory defects. Hence, we have chosen to work with a
conditional allele of Krox20 (Krox20flox) allowing inactivation in endot-
helial-derived cells using the Tie2Cre transgenic mice. Cardiac function
analysis of Krox20 deficient mice was examined by magnetic resonance
imaging. This analysis reveals that Krox20 mutant mice develop an early
aortic insufficiency associated with a bicuspid aortic valve in 30%. Those
defects are usually associated with anomalies of the organization of the
extracellular matrix and abnormal proliferation during valve development.
Thus, Krox20 deficient embryos exhibit an increase of mesenchymal cell
proliferation and a reduction of the expression of some collagens including
type VI collagen. Moreover, the deficiency for Krox20 is associated with
the loss of the trilaminar organization of the adult valves. Our study
reveals an important role of Krox20 in heart valves development, remod-
elling and maturation.
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Long QT syndrome (LQTS) is a rare genetic cardiac disease, with clin-
ical variability, characterized by a prolongation of the QT interval on elec-
trocardiogram and risk of syncope and sudden death. Stratifying the risk
of cardiac events is important for the clinical management of the LQTS
patients. Thus, we investigated the role of genetic variants as modifiers of
cardiac event risk in LQTS patients carrying heterozygous KCNQ1 or
KCNH2 mutations.
We genotyped 25 candidate polymorphisms based on either their asso-
ciation with QTc (QT corrected for heart rate) duration in the general pop-
ulation, or their role in adrenergic response, in a matched case-control
study including 112 LQTS patient duos from France, Italy and Japan.
Duos were composed of two relatives harboring the same mutation; one of
whom experienced cardiac events whereas the other was asymptomatic and
untreated.
As expected, we observed that the presence of cardiac events was associ-
ated with longer QTc (490.7±49.1 ms in symptomatic vs. 462.2±39.8 ms in
asymptomatic patients, p=0.007). The NOS1AP rs12029454 A-allele showed
suggestive evidence of association with longer QTc (484.0±49.6 ms for car-
riers vs. 471.2±44.3 ms for non-carriers, p=0.006), and this effect was homo-
geneous in all ethnic groups. Carriers of the KCNQ1 rs2074238 T-allele
tended to have shorter QTc (464.1±34.9 ms for carriers vs. 479.1±44.0 ms for
non-carriers, p=0.04). This effect was restricted to the Caucasian population
because the SNP (Single Nucleotide Polymorphism) was not polymorphic in
our Japanese cohort. Interestingly, the rs2074238 T-allele was in addition sig-
nificantly associated with a decreased risk of cardiac events (OR=0.38 [0.27-
0.53], p=0.002).
Our results provide the first evidence that rs2074238 in KCNQ1 could be
a risk modifier for cardiac events in Caucasian LQTS patients. After confir-
mation in additional populations, this SNP may be clinically useful for risk
stratification in LQTS patients.
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Background: Oxidative stress and resulting inflammation may participate
in the pathophysiological mechanisms of aneurysm formation and ultimately
to aortic dissection. Aortic dissection more often occurs in the small curvature
(SC) of ascendant aortic aneurysms (AsAA), when compared to large curva-
ture (LC). We investigated the differential expression of oxidative stress and
inflammation in different parts of human aortic tissues, in particular in SC and
LC of patients with asymptomatic AsAA.
Methods: Aortic biopsies were obtained from 24 patients with asymptom-
atic AsAA undergoing elective open replacement, and each sample was
divided in four parts: SC, LC, anterior and posterior parts (A, P). Oxidative
stress was assessed by dihydroethidium (DHE) quantification and amount of
atherosclerosis plaque was determined by Oil Red O. NADPH oxidase subunit
expressions were assessed by PCR on NOX1, NOX2, NOX4 and NOX5.
Western blotting were performed to evaluate the expression of GP91phox,
p47phox, P-NF-B, and IL-1-.
Results: Oxidative stress, assessed by DHE, was around 20% higher in the
SC than other parts of the aortic wall (p<0.001), and lipid deposit was around
50% higher in the SC. A and P parts had the same pattern expression than LC.
NOX2 gene expression was also around 50% higher in SC than in LC whereas
NOX5 was around 20% lower (p<0.001). Expression of NOX1 was similar for
all the parts while NOX4 expression tended to be increased in SC. GP91phox,
p47phox, phosphorylated NF-B expression, and IL-1- expression were signif-
icantly higher in the SC than in the LC (p<0.001).
Conclusion: This study showed a regional heterogeneity of oxidative
stress in the aortic walls of patients withasymptomatic AsAA. Oxidative
stress was markedly higher in the SC than in the LC tissue, mainly linked
to increased NOX2 gene expression. These results further support the
© Elsevier Masson SAS. All rights reserved.
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hypothesis for a central role of vascular oxidative stress in the develop-
ment of AsAA.
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The response of various systems to stressful stimuli is influenced by the
HPA axis. We investigated the contribution of the stress hormone corti-
cotropin (CRH) to cardiac function in basal and stressful conditions in Crh-
null (Crh –/–) and wild-type (Crh+/+) mice. The stressful/ inflammatory
reaction was induced by LPS. Heart Rate (HR), percentage of LV fractional
shortening (FS) and Ejection Fraction (EF) were calculated by echocardio-
graphy. At baseline, cardiac function was compromised in Crh –/– com-
pared to Crh+/+ mice, as shown by cardiac hypertrophy, significantly lower
FS and EF and lower heart rate. Crh –/– had increased levels of apoptosis,
increased perivascular fibrosis and vascular thickness. They exhibited
greatly reduced ERK1/2 and Akt phosphorylation and increased levels of
MMP13. LPS administration significantly reduced FS and EF at 6 and 20h
in Crh+/+ and more drastically in Crh –/– mice. LPS-treated mice had sig-
nificantly increased number of apoptotic cells. Their cardiac muscle showed
higher levels of infiltration and development of fibers surrounding the
hyperplastic vessels, in addition to increased fibrosis-like reactive collagen
production and fibronectin levels. LPS greatly increased levels of IL-6 and
TNF. MMP13, which contribute to the progression of cardiomyopathy
was further increased. Crh –/– had unexpected high levels of mortality (90-
100% 16-28h post-LPS treatment), compared to no mortality among Crh+/+.
To dissect the contribution of glucocorticoid insufficiency in Crh –/–, cor-
ticosterone was replaced for a week prior to LPS treatment, but that
improved the effect of LPS on Crh –/– only when accompanied with an
acute dexamethasone injection. To our knowledge, this is the first indica-
tion of endogenous CRH acting directly in cardiac function and develop-
ment under basal conditions and as a cardioprotective factor in response to
systemic inflammatory stress such as endotoxemia. 
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Atherosclerosis is an inflammatory disease in which the coordination of
angiogenesis and inflammation is achieved by the ability of both endothelial
cells and monocytes to respond to chemokines. We here addressed by both in
vitro and in vivo techniques, the influence of RANTES/CCL5 on angiogen-
esis, and the role of its cellular ligands CCR1, CCR5, syndecan-1 (SDC-1),
syndecan-4 (SDC-4), CD-44 in this effect. 
The angiogenic effects of RANTES/CCL5 or its mutants, [E66A] –
RANTES/CCL5 with impaired ability to oligomerize, and [44AANA47] –
RANTES/CCL5 mutated in the main RANTES/CCL5-GAGs binding site
were analyzed in vivo in a rat-disc model, and in vitro by measuring i/ their
effect on endothelial cell proliferation, migration, spreading and vessels for-
mation in 2D and 3D angiogenesis, ii/ the involvement of RANTES/CCL5
cellular ligands such as G Protein-Coupled Receptors and proteoglycans in
RANTES/CCL5-induced biological effects.
Our data demonstrate that RANTES/CCL5 is pro-angiogenic both in
vitro and in vivo experimental models. This activity depends on RANTES/
CCL5 binding to CCR1, CCR5, SDC-1, SDC-4 or CD-44. Moreover, oli-
gomerization and binding to glycosaminoglycans are essential steps in the
induction of RANTES/CCL5 angiogenic effects. Altogether our results
suggest that the induction of angiogenesis by the chemokine RANTES/
CCL5 lead to new therapeutic approaches for reendothelialization after
vascular injury.
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Objectives: It has been shown that blood levels of Lp-PLA2 predict future
cardiovascular events indepently from traditional cardiovascular risk factors.
Metabolic syndrome has been associated with an increased cardiovascular
risk. The aim of this study was to study the relationship between Lp-PLA2
and metabolic syndrome components.
Methods: Patients were recruited at our outpatient clinic. None should
have any history of cardiovascular diseaseand all underwent routine clinical
and biological assessments. Lp-PLA2 was measured in serum with a Plac Test
turbidimetric immunoassay.
Results: 148 patients were included with a mean age of 53 years. Lp-PLA2
levels ranged from 41 to 407 ng/mL with a mean of 189 ng/ mL (SD: 67 ng/mL).
119 patients (80%) presented with at least 3 NCEP ATPIII criteria of meta-
bolic syndrome and 61 (41) % had treatment for diabetes. 58 patients (39%)
were under statin treatment. Our results showed that neither the presence of
metabolic syndrome, nor the number of its components influenced Lp-PLA2
levels. We found no individual link between each component of the metabolic
syndrome and Lp-PLA2 levels except for diabetes mellitus. There was a neg-
ative correlation between diabetes and Lp-PLA2 that did not persist after
adjustment for lipid lowering treatments. In univariate analysis, we found a
strong linear correlation between Lp-PLA2, LDL-cholesterol (r=0.377
p<0.001). This association existed whereas patients were treated by statins or
not. Accordingly, a statin intake was associated with significantly lower Lp-
PLA2 levels (190 ng/mL vs. 148 ng/mL, p<0.001). There was no correlation
between other traditional risk factors (age, gender, smoking status, blood pres-
sure) and Lp-PLA2 levels.
Conclusion: In our eurocaucasian population of patients with metabolic
syndrome in primary prevention, we confirmed that Lp-PLA2 levels were
totally independent of the components of metabolic syndrome and of any tra-
ditional risk factors. In the opposite, they were strongly correlated with LDL-
C and statin intake. It highlights the fact that interpretation of Lp-PLA2 assay
may need to be adjusted for LDL-C level and lipid lowering therapy to be
completely accurate.
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Introduction: The 894G>T, –786T>C and 4a4b polymorphisms of the
NOS3 gene have been associated with coronary artery disease (CAD) in sev-
eral populations worldwide, but results are still controversial. In the present
study, we examined the association between the 894G>T, –786T>C and 4a4b
polymorphisms of the NOS3 gene and myocardial infarction (MI) in a sample
of the Tunisian population.
Methods: A total of 303 unrelated patients with MI and 225 controls were
included in this study. The 8940G>T and -786T>C single nucleotide polymor-
phisms were analyzed by PCR-RFLP, and 4a4b polymorphism by PCR.
Results: The genotype distribution and the relative allelic frequencies for
the 894G>T and –786T>C polymorphisms were not significantly different
between MI and control subjects (p = NS). Moreover, the odds ratio for MI
associated with the 894T (OR = 1.02, 95% CI 0.76-1.35), –786C (OR = 1.09,
